Can you get medical cannabis for sciatica in the UK?
Sciatica is nerve pain, which puts it in the part of the pain field where cannabis-based medicines have actually been studied. It is also the kind of pain that most often resolves without any of this — which is the first thing a careful specialist will check.
The short answer
- Sciatica is neuropathic pain, which is where the cannabinoid pain evidence sits.
- Most sciatica improves within weeks without specialist drug treatment.
- The Cochrane review of cannabis-based medicines for neuropathic pain judged the evidence low to very low quality.
- NICE advises against gabapentinoids and opioids for sciatica specifically.
- Persistent or worsening weakness needs surgical assessment, not pain management.
Is sciatica treated with medical cannabis in the UK?
Persistent sciatica is assessed privately as a form of neuropathic pain. It is not an NHS treatment and no cannabis-based product is licensed for it.
The timing matters more here than for most conditions. NICE guidance notes that sciatica commonly improves over weeks to months, and the recommended approach early on is to stay active, with exercise and self-management. Treatment decisions in the first few weeks are usually about symptom relief while nature takes its course.
Where sciatica persists for months and has not responded to the recommended approaches, it becomes the kind of chronic neuropathic pain that specialists do assess.
What the evidence actually shows
Sciatica sits inside the neuropathic pain evidence base, which is the best-studied area for cannabis-based medicines and still not a strong one. The Cochrane review found evidence of low to very low quality, with benefits that may be outweighed by harms.
The review behind that paragraph
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2018;3:CD012182. Sixteen studies, 1,750 participants. More people reported a 30% pain reduction than with placebo, and more people also withdrew because of side effects.
No randomised trial has studied cannabis-based medicines in sciatica specifically. What is available is evidence about neuropathic pain in general, which a specialist extrapolates from — and extrapolation is exactly the kind of reasoning that deserves to be stated openly rather than dressed up as proof.
It is also worth knowing what NICE says about the alternatives. For sciatica it advises against gabapentin, pregabalin and opioids, on the grounds that the evidence does not support them either. This is not a field where cannabis has been singled out for scepticism.
What a specialist will want to see
For sciatica the assessment is unusually focused on time and on red flags: how long it has lasted, whether it is improving, and whether anything suggests it needs a surgeon rather than a prescriber.
- How long the sciatica has lasted, and whether it is improving or worsening
- Whether any weakness, numbness or loss of reflexes has been documented
- What imaging has been done, if any, and what it showed
- Whether you have completed physiotherapy or a structured exercise programme
- Which medicines have been tried, and whether NICE-advised-against drugs were used anyway
- Whether a spinal surgical opinion has been sought, where symptoms persist
Numbness around the groin or buttocks, difficulty passing urine, loss of bladder or bowel control, or rapidly worsening leg weakness are emergency symptoms of cauda equina syndrome. Go to A&E immediately. Do not wait for any appointment.
The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?
Risks and reasons a specialist may say no
The main reason for a no in sciatica is timing: pain that has not yet been given the chance to settle, or that has not been properly investigated, is not a good candidate for an unlicensed medicine.
The ordinary cautions apply as elsewhere — drowsiness, dizziness, dry mouth, impaired concentration, and driving impairment, which matters particularly if you are already taking other pain medicines. A personal or family history of psychosis, unstable mental illness, pregnancy or breastfeeding will normally count against treatment.
As with back pain, there is a practical tension worth naming: recovery from sciatica depends on staying active, and a sedating medicine can work against that.
If you want to take this further
The useful next step is a proper assessment, not a longer reading list. Gather your diagnosis, the treatments you have already tried and what happened with each, and a current list of your medicines — that is what a specialist needs in order to give you a straight answer.
The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If sciatica is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.
Frequently asked questions
Can I get medical cannabis for sciatica in the UK?
Persistent sciatica can be assessed privately as a form of neuropathic pain. Nothing is licensed for it. Most sciatica improves over weeks to months, so a specialist will look closely at how long yours has lasted and what has been tried.
Is there a trial of cannabis for sciatica?
Not specifically. The evidence comes from trials of chronic neuropathic pain in general. The Cochrane review of that literature judged the evidence low to very low quality and noted that harms may outweigh benefits.
What does NICE recommend for sciatica?
Staying active, exercise and self-management, with consideration of a surgical opinion where symptoms persist. NICE advises against gabapentin, pregabalin and opioids for sciatica, and against cannabis-based medicines for chronic primary pain.
When is sciatica an emergency?
Numbness around the groin or buttocks, difficulty passing urine, loss of bladder or bowel control, or rapidly worsening leg weakness may indicate cauda equina syndrome. Go to A&E immediately.
Sources and further reading
Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.
- Mücke M, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews (2018)
- NICE guideline NG59: Low back pain and sciatica in over 16s
- NHS: Sciatica
- NICE guideline NG193: Chronic pain (primary and secondary) in over 16s
- NICE guideline NG144: Cannabis-based medicinal products
- NHS: Medical cannabis (and cannabis oils)
- MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use